TITLE:
A Study to Assess Use of Zenapax (Daclizumab) and CellCept (Mycophenolate Mofetil) to Improve Kidney Function in Kidney Transplant Patients

CONDITION:
Kidney Transplantation

INTERVENTION:
Corticosteroids

SUMMARY:

      This study will compare kidney function in kidney transplant patients following treatment
      with various combinations of Zenapax, CellCept, corticosteroids, and Neoral (Cyclosporine).
      The anticipated time on study treatment is 6-12 months, and the target sample size is 500+
      individuals.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  adult patients greater than 18 years of age

          -  recipients of primary kidney transplant

          -  single-organ recipients (kidney only)

        Exclusion Criteria:

          -  previous treatment with Zenapax

          -  history of malignancy (except localized skin cancer)
      
